Announce Date | 05/07/2025 |
EPS Normalized Actual | $-0.58 (Beat by $0.03) |
EPS GAAP Actual | $-0.58 (Beat by $0.03) |
Revenue Actual | $0.8625B |
Revenue Surprise | Beat by $862.5M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.013101 |
EPS GAAP Estimate | $-0.013101 |
Revenue Estimate | $1.3208B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2026 | -0.23818 | -12.39 | -0.97 | 0.18489 | 5 |
Dec 2025 | -0.89458 | -3.3 | -1.47 | -0.6134 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.47 | -0.47 | 0.8625B | -10.31% | 862.5M |
FQ4 2024 (Dec 2024) | -0.33 | -0.33 | 1.3064B | 15.46% | 1306.4M |
FQ3 2024 (Sep 2024) | -0.0001 | -0.0001 | 1.3488B | -4.23% | 1348.8M |
FQ2 2024 (Jun 2024) | -0.1 | -0.1 | 1.0306B | -30.79% | 1030.6M |
FQ1 2024 (Mar 2024) | -0.62 | -0.62 | 0.9514B | 100% | 951.4M |
FQ3 2012 (Sep 2012) | -41.7 | -41.7 | 0.650207B | 100% | 650.21M |
FQ4 2012 (Dec 2012) | -267.87 | -267.87 | 0.613518B | 100% | 613.52M |
FQ4 2023 (Dec 2023) | -0.83 | -0.83 | 1.1044B | 10.28% | 1104.4M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
-0.013101
Consensus Revenue Estimates
1.3208B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.15699 | -- | 0.14971 | 0.16343 | 1 |
FQ3 2027 (Sep 2027) | -0.007807 | -- | -0.00812726 | -0.00744517 | 1 |
FQ2 2027 (Jun 2027) | 0.14745 | -- | 0.14062 | 0.1535 | 1 |
FQ1 2027 (Mar 2027) | -0.20688 | -- | -0.21537 | -0.19729 | 1 |
FQ4 2026 (Oct 2026) | -0.014156 | -- | -0.01547616 | -0.01269706 | 1 |
FQ3 2026 (Jul 2026) | 0.018582 | -- | 0.0166669 | 0.02031492 | 1 |
FQ2 2026 (Jun 2026) | 0.015087 | -- | 0.013471 | 0.01655664 | 1 |
FQ1 2026 (Mar 2026) | -0.32992 | -42.46 | -0.36206 | -0.29458 | 1 |
FQ4 2025 (Oct 2025) | -0.10819 | -205.02 | -0.11828 | -0.09703973 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.55B | -- | 1.49B | 1.6B | 2 |
FQ3 2027 (Sep 2027) | 1.42B | -- | 1.37B | 1.46B | 2 |
FQ2 2027 (Jun 2027) | 1.41B | -- | 1.36B | 1.45B | 2 |
FQ1 2027 (Mar 2027) | 1.09B | -- | 1.05B | 1.13B | 2 |
FQ4 2026 (Oct 2026) | 1.38B | -- | 1.27B | 1.48B | 2 |
FQ3 2026 (Jul 2026) | 1.31B | -- | 1.21B | 1.41B | 2 |
FQ2 2026 (Jun 2026) | 1.29B | -- | 1.18B | 1.38B | 2 |
FQ1 2026 (Mar 2026) | 1.14B | 24.04 | 1.04B | 1.22B | 2 |
FQ4 2025 (Oct 2025) | 1.32B | 0.87 | 1.21B | 1.41B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.47 | -0.47 | 100% | |
FQ4 2024 (Dec 2024) | -0.33 | -0.33 | 100% | |
FQ3 2024 (Sep 2024) | -0.0001 | -0.0001 | 100% | |
FQ2 2024 (Jun 2024) | -0.1 | -0.1 | 100% | |
FQ1 2024 (Mar 2024) | -0.62 | -0.62 | 100% | |
FQ3 2012 (Sep 2012) | -41.7 | -41.7 | 100% | |
FQ4 2012 (Dec 2012) | -267.87 | -267.87 | 100% | |
FQ4 2023 (Dec 2023) | -0.83 | -0.83 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $0.86B | $862.5M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.31B | $1306.4M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.35B | $1348.8M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.03B | $1030.6M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.95B | $951.4M | 100% |
FQ3 2012 (Sep 2012) | $0B | $0.65B | $650.21M | 100% |
FQ4 2012 (Dec 2012) | $0B | $0.61B | $613.52M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.1B | $1104.4M | 100% |